Nicolas Lévêque

Prof. Nicolas Lévêque

Laboratoire Inflammation, Tissus Epithéliaux et Cytokines, LITEC EA 4331, Université de Poitiers, Poitiers, France

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
Laurent AndreolettiLaurent Andreoletti
Laurent Andreoletti
NLNicolas Lévêque
Nicolas Lévêque
CBCamille BOULAGNON-ROMBI
Camille BOULAGNON-ROMBI
CBCamille Brasselet
Camille Brasselet
PFPaul Fornes
Paul Fornes

1 December 2007 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
ACAnne CAMMAS
Anne CAMMAS
FPFrédéric Pileur
Frédéric Pileur
SBSophie Bonnal
Sophie Bonnal
SLStephen Lewis
Stephen Lewis
NLNicolas Lévêque
Nicolas Lévêque
SVStéphan Vagner
Stéphan Vagner
Heterogeneous nuclear ribonucleoprotein (hnRNP) A1 is a nucleocytoplasmic shuttling protein that regulates gene expression through its action on mRNA metabolism and translation. The cytoplasmic redistribution of hnRNP A1 is a regulated process during viral infection and cellular stress. Here, we show that hnRNP A1 is an internal ribosome entry site (IRES) trans-acting factor that binds specifically to the 5′ untranslated region of both the human rhinovirus-2 and the human apoptotic peptidase activating factor 1 (apaf-1) mRNAs, thereby regulating their translation. Furthermore, the cytoplasmic redistribution of hnRNP A1 after rhinovirus infection leads to enhanced rhinovirus IRES-mediated translation, whereas the cytoplasmic relocalization of hnRNP A1 after UVC irradiation limits the UVC-triggered translational activation of the apaf-1 IRES. Therefore, this study provides a direct demonstration that IRESs behave as translational enhancer elements regulated by specific trans-acting mRNA binding proteins in given physiological conditions. Our data highlight a new way to regulate protein synthesis in eukaryotes through the subcellular relocalization of a nuclear mRNA-binding protein.

1 May 2010 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
ATAdissa Tran
Adissa Tran
DTDébOrah Talmud
DébOrah Talmud
BLBenoît Lejeune
Benoît Lejeune
NJNicolas Jovenin
Nicolas Jovenin
Fanny RenoisFanny Renois
Fanny Renois
Laurent AndreolettiLaurent Andreoletti
Laurent Andreoletti
From January to December 2007, 973 stool specimens were prospectively collected from children hospitalized for gastroenteritis signs or from neonates and premature cases who were born in two French hospital settings in the north of France. They were tested by rapid enzyme immunoassay (EIA) analyses for rotavirus and adenovirus and by two commercially available ELISA tests for the detection of norovirus and astrovirus. The overall rates of prevalence for rotavirus, norovirus, adenovirus, and astrovirus were 21, 13, 5, and 1.8%, respectively, and they did not significantly differ between the two hospital settings ( P = 0.12). Mixed virus infections were detected in 32 (3.3%) of the 973 study children and were associated with norovirus in 21 (66%) infants, including 5 premature cases. From fall to spring, norovirus infections accounted for 52% of documented gastroenteritidis viral infections at a time when rotavirus was epidemic, resulting in mixed norovirus and rotavirus gastrointestinal tract infections. Of the 367 documented viral gastroenteritis cases, 15 (4.1%) were identified as nosocomial infections, 5 of which occurred in premature cases. These findings highlight the need to implement norovirus and astrovirus ELISA detection assays in association with rapid EIA rotavirus and adenovirus detection assays for the clinical diagnosis and the nosocomial prevention of gastroenteritis viral infections in pediatric departments.

1 June 2013 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
JCJean-François Coste
Jean-François Coste
VVVincent Vuiblet
Vincent Vuiblet
BMBetoul Moustapha
Betoul Moustapha
ABAlexis Bouin
Alexis Bouin
SLSylvie Lavaud
Sylvie Lavaud
NLNicolas Lévêque
Nicolas Lévêque
Diarrhea is a frequent complication after kidney transplantation, ascribed to adverse effects of the immunosuppressive therapy in case of negative microbiological examination of the stools. The aim of this study was to improve the microbiological diagnosis by implementing molecular tests. Fifty-four severe diarrhea events that occurred in 49 adult kidney transplant recipients from September 2010 to November 2011 were investigated. One or several enteric pathogens were detected in 13 (23%) stool samples using classical microbiological methods versus 39 (72%) for the seven commercially available multiplex PCR assays used retrospectively ( P = 0.006). Interestingly, molecular diagnosis identified 15 multiple infections compared to none using classical techniques. The primary pathogens detected were enteropathogenic Escherichia coli (EPEC) ( n = 15; 38%), Campylobacter spp. ( n = 15; 38%), and Norovirus ( n = 14; 36%). Specificities for Campylobacter and Norovirus infection diagnosis were 75 and 100%, respectively, by comparison to reference methods. Based on molecular findings, a cyclosporine-mycophenolate mofetil combination was identified as a risk factor for developing Norovirus -induced diarrhea. Norovirus infections were also responsible for higher weight loss than all the other causes of diarrhea. In samples from asymptomatic immunocompromised and immunocompetent patients, EPEC but not Norovirus and Campylobacter infections were detected at a frequency similar to that observed in symptomatic kidney transplant recipients. In conclusion, molecular tools significantly improved the detection of single and multiple enteric infections by comparison to classical techniques and could quickly become the key element in the management of severe acute diarrhea in transplant recipients.

3 June 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
CCCéline Chessa
Céline Chessa
CBCharles BODET
Charles BODET
CJClément Jousselin
Clément Jousselin
MWMichel Wehbe
Michel Wehbe
NLNicolas Lévêque
Nicolas Lévêque
MGMagali Garcia
Magali Garcia
Keratinocytes, the main cells of the epidermis, are the first site of replication as well as the first line of defense against many viruses such as arboviruses, enteroviruses, herpes viruses, human papillomaviruses, or vaccinia virus. During viral replication, these cells can sense virus associated molecular patterns leading to the initiation of an innate immune response composed of pro-inflammatory cytokines, chemokines, and antimicrobial peptides. Human keratinocytes produce and secrete at least nine antimicrobial peptides: human cathelicidin LL-37, types 1–4 human β-defensins, S100 peptides such as psoriasin (S100A7), calprotectin (S100A8/9) and koebnerisin (S100A15), and RNase 7. These peptides can exert direct antiviral effects on the viral particle or its replication cycle, and indirect antiviral activity, by modulating the host immune response. The purpose of this review is to summarize current knowledge of antiviral and immunomodulatory properties of human keratinocyte antimicrobial peptides.

20 February 2007 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
NJNina Junttila
Nina Junttila
NLNicolas Lévêque
Nicolas Lévêque
JKJean Pierre Kabue
Jean Pierre Kabue
GCGaëlle Cartet
Gaëlle Cartet
FMFidèle Mushiya
Fidèle Mushiya
HNHeléne Norder
Heléne Norder